mRNA therapy company SRTD Biotech has completed a €31.5 million seed round financing, led by Mérieux Equity Partners

2026-11-09 20:52:45

SRTD Biotech, a German mRNA therapy company, has completed an oversubscribed seed round financing of 31.5 million euros, led by Mérieux Equity Partners, with NRW.BANK and Boehringer Ingelheim Venture Fund co-leading.

The funds will be used to advance the seRNA platform that expresses only in diseased cells and LNP delivery.

source

warnning

Risk warning

Related tags

SRTD Biotech Mérieux Equity Partners funding and investment

Related reading

AI intelligent entity simulation platform Plurai completed a $13 million seed round financing, led by Team8

2026-11-11 23:03

AI data company Edelbyte completed a $70 million seed and Series A financing round, led by Sequoia Capital

2026-11-11 22:10

AI sales startup Rox completed a $100 million Series B funding round at a valuation of $1.3 billion, led jointly by General Catalyst and March Capital

2026-11-11 21:23

Semiconductor startup Tendrils has completed a $30 million seed round financing, led by Benchmark

2026-11-11 19:52

Related tags

SRTD Biotech Mérieux Equity Partners funding and investment

app_icon

ChainCatcher Building the Web3 world with innovations.